Skip to main content
Signal8

CLAUSEN PETER

SEC insider (Form 3/4/5 filer). CIK 0001605411. CSO/COO at Nuo Therapeutics, Inc. (AURX). 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 29, 2026. Located in HOUSTON, TX.

Companies CLAUSEN PETER has filed insider reports for

  • Nuo Therapeutics, Inc. (AURX): Officer, CSO/COO
CLAUSEN PETER profile photo

CLAUSEN PETER

CIK: 0001605411

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (66.7%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Nuo Therapeutics, Inc. logo
AURX

Nuo Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Nuo Therapeutics, Inc. logo
    AURX

    Nuo Therapeutics, Inc.

    Jun 29, 2026
    Award

    Option to purchase common stock

    Direct
    65K shares-
  • Nuo Therapeutics, Inc. logo
    AURX

    Nuo Therapeutics, Inc.

    Jul 31, 2025
    Exercise
    Direct
    183.9K shares at avg. $0.40$74K
  • Nuo Therapeutics, Inc. logo
    AURX

    Nuo Therapeutics, Inc.

    Aug 9, 2018
    Exercise

    Option to purchase common stock

    Direct
    183.9K shares-

1-3 of 3